Editorial
Volume: 13 | Issue: 1 | Published: Nov 25, 2023 | Pages: 02 - 05 | DOI: 10.24911/PJNMed.175-1700024923
Navigating thyroid cancer: a theranostics odyssey "joining the dots to make a line"
Authors:
Muhammad Babar Imran
, Nayyar Rubab
Article Info
Authors
Muhammad Babar Imran
Editor in Chief, Pakistan Journal of Nuclear Medicine, Department of Nuclear Medicine, PINUM Cancer Hospital, Faisalabad, Pakistan
Nayyar Rubab
SMO, PINUM Cancer Hospital, Faisalabad, Pakistan
Publication History
Received: November 15, 2023
Accepted: November 20, 2023
Published: November 25, 2023
Abstract
Over the past few decades, the incidence of thyroid cancer, which was once a relatively uncommon aspect of oncology, has significantly increased worldwide. This tendency makes opening of new horizons, and finding new modalities for both its diagnosis and therapy all the more crucial. The concept of theranostics in thyroid cancer has shown potential in individualizing treatments, tailoring therapies to the specific molecular characteristics of the patient's cancer.
Keywords: N/A
